CLINICAL_TRIALS
trial_result
· 2018-01-09
Clinical Trial Update: Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism [Phase 3]
Summary
Phase 3 trial update on subcutaneous testosterone replacement in adult men with hypogonadism, reporting efficacy and safety data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Antares Pharma Inc. | Conditions: Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2018-01-09